• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    148.36 UNCHANGED
    Delayed Quote Updated: 7:00 PM EST, Nov 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Merck & Co

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    Here's Why I Think Every Investor Needs to Invest in These "Miracle" Drugs ↗
    The market for GLP-1 drugs is forecast to explode. It may be understated still. 
    Via The Motley Fool
    News headline image
    Why Merck Stock Flew Higher on Friday ↗
    Investors were still buying it in the afterglow of its latest quarterly earnings release. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    MRK Q3 deep dive: oncology launches, clinical pipeline advances, and margin headwinds
    Global pharmaceutical company Merck (NYSE:MRK) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 4.7% year on year to $18.09 bil... 
    Via StockStory
    News headline image
    Merck & Co., Inc. Q3 Earnings Call Highlights ↗
    Merck & Co., Inc. (NYSE:MRK) reported third-quarter 2026 revenue of $18.1 billion, up 5% from a year earlier, as growth in oncology, vaccines, cardiometabolic products and animal health helped offset... 
    Via MarketBeat
    Topics Earnings
    Merck & Co. (NYSE:MRK) Posts Q3 Earnings Beat as EPS Surprise Offsets In-Line Sales Guidance ↗
    Via Chartmill
    Topics Earnings
    Dow Jones Top Gainers in Today's Session: 3M Leads ↗
    Via Chartmill
    Topics Stocks
    Dow Jones Top Movers for Oct. 29, 2026: Merck and Nike Lead Gainers, Alphabet and Caterpillar Fall ↗
    Via Chartmill
    Topics Stocks
    News headline image
    Merck (MRK) Q3 2026 Earnings Call Transcript ↗
    Generic headwinds ahead in 2027, but new launches and WINREVAIR growth signal momentum. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Merck Lifts Outlook on a Lower Tax Rate: Rapid Earnings Reaction ↗
    Merck’s new drugs are growing fast enough to cover generic losses, but part of this quarter’s sales gain won’t last. Here’s what to watch. 
    Via The Motley Fool
    Topics Intellectual Property
    Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session ↗
    Via Chartmill
    Topics Stocks
    Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings ↗
    Via Chartmill
    Merck & Co. (NYSE:MRK): A Quality Investing Case With Strong ROIC but Revenue Growth Concerns ↗
    Via Chartmill
    Dow Jones Top Movers Today: 8 Gainers, 4 Losers in Split Session ↗
    Via Chartmill
    Topics Stocks
    News headline image
    Merck (NYSE:MRK) delivers impressive Q3 2026
    Global pharmaceutical company Merck (NYSE:MRK) announced better-than-expected revenue in Q3 2026, with revenue rising 4.7% year on year to $18.09 billion. Th... 
    Via StockStory
    News headline image
    Could Revolution Medicines Be a Millionaire-Maker Stock? ↗
    The path for Revolution Medicines to grow an initial investment of $25,000 into $1 million is a daunting one. 
    Via The Motley Fool
    News headline image
    Merck (MRK) reports Q3: everything you need to know ahead of earnings
    Global pharmaceutical company Merck (NYSE:MRK) will be reporting earnings this Thursday before market open. Here’s what investors should know. Merck beat ana... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Merck and Moderna's Cancer Vaccine Worked—Who Gets Paid? ↗
    Merck and Moderna's melanoma vaccine cut recurrence risk 42% in a Phase 3 trial, but results fell short of hopes, sending Moderna shares down sharply while Merck stock barely moved. 
    Via MarketBeat
    News headline image
    Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts ↗
    Merck & Co., Inc. (NYSE:MRK) outlined new oncology data and development plans at the European Society for Medical Oncology annual meeting, highlighting phase III results for its sacituzumab... 
    Via MarketBeat
    S&P 500 Top Movers: Gainers and Losers in Today's US Session ↗
    Via Chartmill
    Topics Stocks
    News headline image
    Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts ↗
    MercadoLibre, Novo Nordisk, Tyler Technologies and Summit Therapeutics trade below recent highs, yet each has earnings or catalysts that could shift sentiment. 
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach ↗
    Lincoln National, AbbVie and Phillips 66 offer dividends that pay investors through midterm volatility, backed by rising rates, steady drug demand and oil risk. 
    Via MarketBeat
    News headline image
    Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 ↗
    The market has rewarded this biotech for its breakthroughs. 
    Via The Motley Fool
    News headline image
    Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice ↗
    This company made headlines with its coronavirus vaccine. 
    Via The Motley Fool
    News headline image
    2 High-Flying Dividend Stocks to Buy and Hold for a Decade ↗
    They may just be getting started. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning ↗
    AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound. 
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys ↗
    These funds can help you weather any storm that might be on the way. 
    Via The Motley Fool
    Topics ETFs Stocks
    News headline image
    Novo Nordisk and Eli Lilly Just Got Some Fantastic News ↗
    A new government-funded study found that GLP-1 drugs slow the aging process in mice. 
    Via The Motley Fool
    Discover which dow jones stocks are making waves on Thursday. ↗
    Via Chartmill
    Stock Market Today: Hot Inflation and a Neocloud Shakeout Sink the Nasdaq ↗
    Via Chartmill
    Topics Economy
    Discover which dow jones stocks are making waves on Wednesday. ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.